A new smartphone application uses artificial intelligence to detect depression from facial cues, opening the door to real-time digital mental health support, a new research paper reports.
The FDA approves an oral medication to treat clinical depression: Auvelity from Axsome Therapeutics. Clinical trials found it starts working within one week.
Axsome Therapeutics (AXSM) Announces FDA Approval of AUVELITY streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Form 8-K Axsome Therapeutics, For: Aug 19 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
In major depressive disorder (MDD), pharmacogenomic tests can help reduce drug-gene interactions related to antidepressants, leading to better selection and optimal dosing of the med, new research suggests.